# Neumora Therapeutics, Inc. Common Stock (NMRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NMRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -53.46M | $ -46.40M | N/A | $ 70.68M |
| 2025 | $ 0 | $ -242.59M | $ -211.38M | $ 477.0K | $ 103.87M |
| 2024 | $ 0 | $ -256.24M | $ -192.28M | $ 1.85M | $ 287.06M |
| 2023 | $ 0 | $ -255.09M | $ -176.67M | $ 5.23M | $ 469.08M |
| 2022 | $ 0 | $ -146.23M | $ -128.92M | $ 8.44M | $ -446.85M |
| 2021 | $ 0 | $ -282.08M | $ -90.62M | $ 2.05M | $ -325.22M |
| 2020 | $ 0 | $ -25.48M | $ -22.69M | $ 2.05M | $ -94.38M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 1.18 |
| Current Ratio | 5.09 |

## Other views

- [Metrics](https://sponda.capital/en/NMRA.md)
- [Charts](https://sponda.capital/en/NMRA/charts.md)
- [Compare](https://sponda.capital/en/NMRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.